Biome Australia
- Short interest
- 0.02%
- +0.02 pp 30d
- as of 8 Oct 2026
- Reported shorts
- 39.2K
- Shares on issue
- 231.407M
Biome Australia (BIO) Short Interest
Biome Australia (ASX:BIO) had 0.02% of shares reported as short positions as of 8 Oct 2026, representing 39,214 shares. Biome Australia operates in the Household & Personal Products industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Biome Australia
Biome Australia focuses on the licensing, development, and marketing of complementary medicines, including nutraceuticals and live biotherapeutics. The company operates within the household and personal products industry, aiming to provide innovative health solutions. Biome Australia distributes their products through pharmacies and health food stores.
Company profile →Biome Australia (ASX:BIO) has 0.02% of its shares on issue reported as short positions as of 8 Oct 2026, or about 39,214 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.06 percentage points. Its highest recorded short interest was 0.26% in January 2025. BIO is classified in the Household & Personal Products industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads BIO today
- Zanger BreakoutWatchScore 35rank 331 of 1931
- CAN SLIMWatchScore 47rank 52 of 1541
- Minervini Trend TemplateWatchScore 39rank 430 of 1736
- Crowded-Short BreakoutWatchScore 15rank 575 of 1479
- Quality compoundersWatchScore 35rank 307 of 1677
Prices to 13 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
BIO fundamentals
In the year to 30 Jun 2026, Biome Australia (ASX:BIO) recorded revenue of A$23.9M and net profit after tax of A$3.6M. A year earlier it recorded revenue of A$18.4M and net profit after tax of A$214.7K. Year-on-year growth: revenue +29.7% (FY). Net margin 15.1% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit), as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest BIO news
All news- Change of Auditor
asx · 4 Oct 2026
- Secondary Trading Notice
asx · 24 Sept 2026
- Application for quotation of securities - BIO
asx · 24 Sept 2026
Company details
website
address
More Household & Personal Products Stocks
Other shorted stocks in this sector
Be the first to discuss BIO
Start a research thread or post the first pulse update